Alwisi, N.; Ismail, R.; Al-Kuwari, H.; Al-Ansari, K.H.; Al-Matwi, M.A.; Aweer, N.A.; Al-Marri, W.N.; Al-Kubaisi, Y.; Al-Mohannadi, M.; Hamran, S.;
et al. Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines 2025, 13, 702.
https://doi.org/10.3390/biomedicines13030702
AMA Style
Alwisi N, Ismail R, Al-Kuwari H, Al-Ansari KH, Al-Matwi MA, Aweer NA, Al-Marri WN, Al-Kubaisi Y, Al-Mohannadi M, Hamran S,
et al. Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines. 2025; 13(3):702.
https://doi.org/10.3390/biomedicines13030702
Chicago/Turabian Style
Alwisi, Nouran, Rana Ismail, Hissa Al-Kuwari, Khalifa H. Al-Ansari, Mohammed A. Al-Matwi, Noor A. Aweer, Wejdan N. Al-Marri, Yousif Al-Kubaisi, Muneera Al-Mohannadi, Shahd Hamran,
and et al. 2025. "Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis" Biomedicines 13, no. 3: 702.
https://doi.org/10.3390/biomedicines13030702
APA Style
Alwisi, N., Ismail, R., Al-Kuwari, H., Al-Ansari, K. H., Al-Matwi, M. A., Aweer, N. A., Al-Marri, W. N., Al-Kubaisi, Y., Al-Mohannadi, M., Hamran, S., Doi, S. A. R., Farooqui, H. H., & Chivese, T.
(2025). Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines, 13(3), 702.
https://doi.org/10.3390/biomedicines13030702